Cargando…
The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use
Ovarian cancer is one of the most lethal gynecological malignancies worldwide because it tends to be detected late, when the disease has already spread, and prognosis is poor. In this review we aim to highlight the importance of long non-coding RNAs (lncRNAs) in diagnosis, prognosis and treatment ch...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225988/ https://www.ncbi.nlm.nih.gov/pubmed/32326249 http://dx.doi.org/10.3390/cancers12041020 |
_version_ | 1783534181754601472 |
---|---|
author | Salamini-Montemurri, Martín Lamas-Maceiras, Mónica Barreiro-Alonso, Aida Vizoso-Vázquez, Ángel Rodríguez-Belmonte, Esther Quindós-Varela, María Cerdán, María Esperanza |
author_facet | Salamini-Montemurri, Martín Lamas-Maceiras, Mónica Barreiro-Alonso, Aida Vizoso-Vázquez, Ángel Rodríguez-Belmonte, Esther Quindós-Varela, María Cerdán, María Esperanza |
author_sort | Salamini-Montemurri, Martín |
collection | PubMed |
description | Ovarian cancer is one of the most lethal gynecological malignancies worldwide because it tends to be detected late, when the disease has already spread, and prognosis is poor. In this review we aim to highlight the importance of long non-coding RNAs (lncRNAs) in diagnosis, prognosis and treatment choice, to make progress towards increasingly personalized medicine in this malignancy. We review the effects of lncRNAs associated with ovarian cancer in the context of cancer hallmarks. We also discuss the molecular mechanisms by which lncRNAs become involved in cellular physiology; the onset, development and progression of ovarian cancer; and lncRNAs’ regulatory mechanisms at the transcriptional, post-transcriptional and post-translational stages of gene expression. Finally, we compile a series of online resources useful for the study of lncRNAs, especially in the context of ovarian cancer. Future work required in the field is also discussed along with some concluding remarks. |
format | Online Article Text |
id | pubmed-7225988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72259882020-05-18 The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use Salamini-Montemurri, Martín Lamas-Maceiras, Mónica Barreiro-Alonso, Aida Vizoso-Vázquez, Ángel Rodríguez-Belmonte, Esther Quindós-Varela, María Cerdán, María Esperanza Cancers (Basel) Review Ovarian cancer is one of the most lethal gynecological malignancies worldwide because it tends to be detected late, when the disease has already spread, and prognosis is poor. In this review we aim to highlight the importance of long non-coding RNAs (lncRNAs) in diagnosis, prognosis and treatment choice, to make progress towards increasingly personalized medicine in this malignancy. We review the effects of lncRNAs associated with ovarian cancer in the context of cancer hallmarks. We also discuss the molecular mechanisms by which lncRNAs become involved in cellular physiology; the onset, development and progression of ovarian cancer; and lncRNAs’ regulatory mechanisms at the transcriptional, post-transcriptional and post-translational stages of gene expression. Finally, we compile a series of online resources useful for the study of lncRNAs, especially in the context of ovarian cancer. Future work required in the field is also discussed along with some concluding remarks. MDPI 2020-04-21 /pmc/articles/PMC7225988/ /pubmed/32326249 http://dx.doi.org/10.3390/cancers12041020 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Salamini-Montemurri, Martín Lamas-Maceiras, Mónica Barreiro-Alonso, Aida Vizoso-Vázquez, Ángel Rodríguez-Belmonte, Esther Quindós-Varela, María Cerdán, María Esperanza The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use |
title | The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use |
title_full | The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use |
title_fullStr | The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use |
title_full_unstemmed | The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use |
title_short | The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use |
title_sort | challenges and opportunities of lncrnas in ovarian cancer research and clinical use |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225988/ https://www.ncbi.nlm.nih.gov/pubmed/32326249 http://dx.doi.org/10.3390/cancers12041020 |
work_keys_str_mv | AT salaminimontemurrimartin thechallengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse AT lamasmaceirasmonica thechallengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse AT barreiroalonsoaida thechallengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse AT vizosovazquezangel thechallengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse AT rodriguezbelmonteesther thechallengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse AT quindosvarelamaria thechallengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse AT cerdanmariaesperanza thechallengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse AT salaminimontemurrimartin challengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse AT lamasmaceirasmonica challengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse AT barreiroalonsoaida challengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse AT vizosovazquezangel challengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse AT rodriguezbelmonteesther challengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse AT quindosvarelamaria challengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse AT cerdanmariaesperanza challengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse |